~~<i id='BAF6762B1D'><strike id='BAF6762B1D'><tt id='BAF6762B1D'><pre id='BAF6762B1D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

fashion

author：fashion 2025-09-07 06:39:19 - browse：931

Biotech and life sciences investors continue to draw in new funds even as the biotech stock indexes reach new lows.

On Wednesday, VC firm Bioluminescence Ventures launched with $477 million to invest in biotech startups. The firm was founded by Kouki Harasaki, who was previously a partner at M12, Microsoft’s corporate venture group, and Andreessen Horowitz. He also has a track record at pharmaceutical companies like Novartis and Baxalta.

Bioluminescence joined at least four other firms — OrbiMed, Sofinnova Partners, Abingworth, and Revelation Partners — in announcing new pools of capital in the last two weeks. Together, they have raised $5.94 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections
Next article： Liver decline slowed by off

entertainment

Wikipedia

explore

focus

leisure time

Inthe2011film"Limitless,"mysterypillsletBradleyCooper'sstrugglingwriteraccess100percentofhisbrain,ma

WSS

Digital health: a case of mistaken identity

AI for drug discovery: Experts on separating hype from reality

Has Bernie Sanders reached the limit of his pharma bullying effort?

As billionaires fund anti

Lawmakers grill UnitedHealth CEO on Change cyberattack

Fentanyl is making it harder to start addiction treatment

knowledge

fashion

entertainment

How one medical school became remarkably diverse

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Bright Health sells Medicare Advantage business to Molina

BIO to announce reorganization, senior leaders expected to depart

Activists slam private health insurers over coverage restrictions

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

At least 13 dead in Texas as scorching temps continue

Study finds gene variants tied to breast cancer risk in Black women

entertainment

PBM executives asked to testify by House panel

For longer

As health system earnings go up, health insurance stocks go down

Eyeing GLP

Investigation reveals sickle cell patients pressured into sterilizations

Eyeing GLP

Wikipedia

explore

focus

leisure time